Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • GSK Pharma

    Tag: GSK Pharma

    You Searched For "GSK Pharma"
    GSK Pharma reports Q2 profit at Rs 503 crore

    GSK Pharma reports Q2 profit at Rs 503 crore

    Medical Dialogues Bureau1 Nov 2019 9:15 AM IST
    GSK Pharmaceuticals continues to drive improved operational efficiencies reflecting in earnings before interest, tax, depreciation and amortisation...
    GSK decides to recall antacid Zinetac over safety concern

    GSK decides to recall antacid Zinetac over safety concern

    Medical Dialogues Bureau26 Sept 2019 4:54 PM IST
    New Delhi: GlaxoSmithKline Pharmaceuticals Ltd on Wednesday announced recall of ranitidine hydrochloride tablets produced in India using API sourced...
    GSK Pharma sells 60 acres land in Thane to Oberoi Realty for Rs 890 crore

    GSK Pharma sells 60 acres land in Thane to Oberoi Realty for Rs 890 crore

    Medical Dialogues Bureau31 Aug 2019 12:54 PM IST
    Mumbai: Glaxo Smith Kline Pharmaceuticals (GSK) has divested around 60 acres of its lands at Thane in favour of Oberoi Realty for nearly Rs 890 crore...
    GSK to fund doctoral programs at Government established Regional Centre for Biotechnology

    GSK to fund doctoral programs at Government established Regional Centre for Biotechnology

    Medical Dialogues Bureau27 Jun 2019 9:30 AM IST
    Under this initiative, the RCB will develop program content, manage logistics and oversee the running of the full-time programs while GSK...
    GSK pharma head flags need for speed in high-pressure drug market

    GSK pharma head flags need for speed in high-pressure drug market

    Medical Dialogues Bureau18 Jun 2019 2:06 PM IST
    LONDON: Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at...
    GSK Pharma Q4 net profit rises 16.56 percent to Rs 123 crore

    GSK Pharma Q4 net profit rises 16.56 percent to Rs 123 crore

    Garima21 May 2019 9:30 AM IST
    The company had posted a net profit of Rs 105.55 crore for the corresponding period of the previous fiscal, GSK said in a filing to the BSE.New Delhi:...
    GSK expects shingles drug sales to exceed $1.3 billion

    GSK expects shingles drug sales to exceed $1.3 billion

    Garima2 May 2019 9:00 AM IST
    FTSE-100 member GSK, whose shares were up 0.3 per cent to 1,580 pence at 1156 GMT, also said it had decided to stop the clinical development of its...
    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Medical Dialogues Bureau18 Sept 2018 12:47 PM IST
    Supreme court lifted the ban on the sale of Piramal Healthcare's Saridon, GlaxoSmithKline's Piriton, Juggat Pharma's Dart and another drug, banned...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok